{
"NDC": {
"NDCCode": "72205-354-85",
"PackageDescription": "1 BOTTLE in 1 CARTON (72205-354-85) / 250 mL in 1 BOTTLE",
"NDC11Code": "72205-0354-85",
"ProductNDC": "72205-354",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Oxcarbazepine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Oxcarbazepine",
"DosageFormName": "SUSPENSION",
"RouteName": "ORAL",
"StartMarketingDate": "20260529",
"EndMarketingDate": null,
"MarketingCategoryName": "ANDA",
"ApplicationNumber": "ANDA209020",
"LabelerName": "Novadoz Pharmaceuticals LLC",
"SubstanceName": "OXCARBAZEPINE",
"StrengthNumber": "300",
"StrengthUnit": "mg/5mL",
"Pharm_Classes": "Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2026-06-04",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20271231",
"StartMarketingDatePackage": "20260529",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}